CRYOPORT, INC. Money Market Funds, at Carrying Value
CRYOPORT, INC. (CYRX) had Money Market Funds, at Carrying Value of $230.85 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:MoneyMarketFundsAtCarryingValue · last filed 2026-08-06
- 2026-06-30: Money Market Funds, at Carrying Value $230.85M.
- 2026-03-31: Money Market Funds, at Carrying Value $230.71M.
- 2025-12-31: Money Market Funds, at Carrying Value $208.12M.
- 2025-09-30: Money Market Funds, at Carrying Value $216.47M.
| Period end | Money Market Funds, at Carrying Value | Money Market Funds, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $230.85M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $230.71M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $208.12M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $216.47M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $204.48M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $3.16M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $134.00K 10-K · filed 2026-03-05 | |
| 2024-09-30 | $623.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $5.47M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $7.08M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $5.37M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $18.71M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $33.15M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $2.54M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $1.84M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $1.86M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $8.27M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $101.80M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $111.31M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $14.38M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $30.75M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $61.58M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $11.82M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $92.64M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $27.36M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $44.08M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $43.69M 10-K · filed 2021-03-01 | $43.69M 10-K · filed 2020-03-10 |
| 2019-09-30 | $41.36M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.17M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $622.79K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $103.43K 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |